Idesolide inhibits the adipogenic differentiation of mesenchymal cells through the suppression of nitric oxide production

European Journal of Pharmacology

Volumn 685, Issue 1-3, 2012, Pages 218-223

  Hwang, Jun Ha ^a   Moon, Sung Ah ^a   Lee, Cham Han ^a   Byun, Mi Ran ^a   Kim, A Rum ^a   Sung, Mi Kyung ^a   Park, Hyun Jin ^a   Hwang, Eun Sook ^b   Sung, Sang Hyun ^c   Hong, Jeong Ho ^a  

^a Korea University   (South Korea)

^b Ewha Womans University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Adipogenic differentiation; Idesolide; Nitric oxide; Obesity

Indexed keywords

ANTIOBESITY AGENT; IDESOLIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADIPONECTIN GENE; AP2 GENE; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME REPRESSION; HUMAN; HUMAN CELL; MARKER GENE; MESENCHYME CELL; PRIORITY JOURNAL;

EID: 84861348597     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.04.018     Document Type: Article

References (30)

1. Aouadi, M., Jager, J., Laurent, K., Gonzalez, T., Cormont, M., Binetruy, B., Le Marchand- Brustel, Y., Tanti, J.F., Bost, F., 2007. p38MAP Kinase activity is required for human primary adipocyte differentiation. FEBS Lett. 581, 5591-5596.
2. Balon, T.W., Jasman, A.P., Young, J.C., 1999. Effects of chronic N(omega)-nitro-L-arginine methyl ester administration on glucose tolerance and skeletal muscle glucose transport in the rat. Nitric Oxide 3, 312-320.
3. Butler, R., Morris, A.D., Struthers, A.D., 1998. Systemic nitric oxide synthase inhibition increases insulin sensitivity in man. Clin. Sci. (Lond) 94, 175-180.
4. Calabrese, V., Cornelius, C., Rizzarelli, E., Owen, J.B., Dinkova-Kostova, A.T., Butterfield, D.A., 2009. Nitric oxide in cell survival: a janus molecule. Antioxid. Redox Signal. 11, 2717-2739.
5. Cristancho, A.G., Lazar, M.A., 2011. Forming functional fat: a growing understanding of adipocyte differentiation. Nat. Rev. Mol. Cell Biol. 12, 722-734.
6. Dallaire, P., Bellmann, K., Laplante, M., Gelinas, S., Centeno-Baez, C., Penfornis, P., Peyot, M.L., Latour, M.G., Lamontagne, J., Trujillo, M.E., Scherer, P.E., Prentki, M., Deshaies, Y., Marette, A., 2008. Obesemice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. Diabetes 57, 1999-2011.
7. DeFronzo, R.A., 2010. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53, 1270-1287.
8. Forman, H.J., Torres, M., 2001. Redox signaling in macrophages. Mol. Aspects Med. 22, 189-216.
9. Fujimoto, M., Shimizu, N., Kunii, K., Martyn, J.A., Ueki, K., Kaneki, M., 2005. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54, 1340-1348.
10. Haslam, D.W., James, W.P., 2005. Obesity. Lancet 366, 1197-1209.
11. Juan, C.C., Chang, C.L., Chuang, T.Y., Huang, S.W., Kwok, C.F., Ho, L.T., 2006. Insulin sensitivity and resistin expression in nitric oxide-deficient rats. Diabetologia 49, 3017-3026.
12. Jung, M.H., Yoo, J.M., Kang, Y.J., Lee, H.W., Kim, S.H., Sung, S.H., Lee, Y.J., Choi, I., Kim, T.J., 2010. Idesolide, an isolate of Idesia polycarpa, inhibits apoptosis through induction of intracellular heat shock protein 70 in C2C12 muscle cells. Biol. Pharm. Bull. 33, 1063-1066.
13. Kapur, S., Bedard, S., Marcotte, B., Cote, C.H., Marette, A., 1997. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes 46, 1691-1700.
14. Kawachi, H., Moriya, N.H., Korai, T., Tanaka, S.Y., Watanabe, M., Matsui, T., Kawada, T., Yano, H., 2007. Nitric oxide suppresses preadipocyte differentiation in 3T3-L1 culture. Mol. Cell. Biochem. 300, 61-67.
15. Kim, S.H., Sung, S.H., Choi, S.Y., Chung, Y.K., Kim, J., Kim, Y.C., 2005. Idesolide: a new spiro compound from Idesia polycarpa. Org. Lett. 7, 3275-3277.
16. Kopelman, P.G., 2000. Obesity as a medical problem. Nature 404, 635-643.
17. Kuzin, B., Roberts, I., Peunova, N., Enikolopov, G., 1996. Nitric oxide regulates cell proliferation during Drosophila development. Cell 87, 639-649.
18. Mujoo, K., Krumenacker, J.S., Murad, F., 2011. Nitric oxide-cyclic GMP signaling in stem cell differentiation. Free Radic. Biol. Med. 51, 2150-2157.
19. Nathan, C., Xie, Q.W., 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78, 915-918.
20. Patel, R.P., Levonen, A., Crawford, J.H., Darley-Usmar, V.M., 2000. Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis. Cardiovasc. Res. 47, 465-474.
21. Perreault, M., Marette, A., 2001. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 7, 1138-1143.
22. Rondinone, C.M., 2006. Adipocyte-derived hormones, cytokines, and mediators. Endocrine 29, 81-90.
23. Rosen, E.D., MacDougald, O.A., 2006. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 7, 885-896.
24. Rosen, E.D., Sarraf, P., Troy, A.E., Bradwin, G., Moore, K., Milstone, D.S., Spiegelman, B.M., Mortensen, R.M., 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4, 611-617.
25. Rosen, E.D., Walkey, C.J., Puigserver, P., Spiegelman, B.M., 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14, 1293-1307.
26. Sugita, H., Kaneki, M., Tokunaga, E., Sugita, M., Koike, C., Yasuhara, S., Tompkins, R.G., Martyn, J.A., 2002. Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 282, E386-E394.
27. Sugita, H., Fujimoto, M., Yasukawa, T., Shimizu, N., Sugita, M., Yasuhara, S., Martyn, J.A., Kaneki, M., 2005. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J. Biol. Chem. 280, 14203-14211.
28. Tamori, Y., Masugi, J., Nishino, N., Kasuga, M., 2002. Role of peroxisome proliferatoractivated receptor-gamma in maintenance of the characteristics of mature 3T3- L1 adipocytes. Diabetes 51, 2045-2055.
29. Torres, S.H., De Sanctis, J.B., de L.B., M., Hernandez, N., Finol, H.J., 2004. Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J. Endocrinol. 181, 419-427.
30. Vaandrager, A.B., de Jonge, H.R., 1996. Signalling by cGMP-dependent protein kinases. Mol. Cell. Biochem. 157, 23-30.